critical care of heart transplantation. heart transplant 1960s: first heart transplants performed...

55
Critical Care of Heart Transplantation

Upload: polly-mckinney

Post on 16-Jan-2016

220 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Critical Care of Heart Transplantation

Heart Transplant1048708 1960s

1048708 First heart transplants performed

1048708 1980s

1048708 Anti-rejection meds became available (Cyclosporine)

1048708 Today

1048708 About 80 of heart transplants are alive two years after the operation

1048708 50 percent survive 5 years

042123 2dr yekehfallah-phd of nursing -2015

Clinical Indications forHeart Transplant

1048708 Ischemic cardiomyopathy

1048708 Idiopathic cardiomyopathy

1048708 Viral cardiomyopathy

1048708 Congenital heart disease

1048708 Valvular heart disease

042123 3dr yekehfallah-phd of nursing -2015

Heart Transplant Contraindications

Absolute ContraindicationsI A Systemic illness that will limit survival despite heart

translplantII NeoplasmIII HIVAIDS CDC definition of CD4 count of lt 200 cellsmm3

IV SLE or Sarcoid that has multisystem involvement and is still active

V Any systemic illness with a high probability of recurrence in the transplanted heart

VI B Fixed pulmonary hypertension

042123 4dr yekehfallah-phd of nursing -2015

Heart Transplant Contraindications Relative Contraindications

Age over 65 Peripheral vascular disease Asymptomatic carotid stenosis gt 75 or symptomatic

carotid stenosis of less severity

Uncorrected abdominal aortic aneurysm gt 4 ndash 6 cm Systemic infection making immune suppression risky

HIV HBV CMV (positive donor to negative recipient) Severe pulmonary disease

042123 5dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Left andor Right Heart Catherization

1048708 Echocardiogram

1048708 EKG

1048708 24 hour Holter Monitor

1048708 Carotid and peripheral doppler flow studies

1048708 Cardiopulmonary Stress Test

1048708 Metabolic exercise test that determines the

maximal oxygen consumption

042123 6dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Pulmonary

1048708 Chest radiograph

1048708 CT Chest

1048708 PFTrsquos ndash baseline screening spirometry

042123 7dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Renal

1048708 Urinalysis

1048708 24 hour urine for creatinine clearance

1048708 Renal ultrasound

1048708 Gastrointestinal

1048708 Stool guiac

1048708 Abdominal ultrasound

1048708 CT abdominal and pelvis

1048708 Colonoscopy

042123 8dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Antibody screen

1048708 HLA typing

1048708 Infectious disease serologies

1048708 General laboratory studies

1048708 Bone density scan

1048708 Cancer screens ndash gender specific tests

042123 9dr yekehfallah-phd of nursing -2015

Social Services Psychiatry NeuropsychiatryConsults and Evaluation

1048708 Compliance

1048708 Support

1048708 Depression

1048708 Anxiety

1048708 Substance abuse

1048708 Finances

1048708 Knowledge deficits

042123 10dr yekehfallah-phd of nursing -2015

Medical Management of Patientson Waiting List

Comprehensive CHF Management

Program

042123 11dr yekehfallah-phd of nursing -2015

Patient Education

1048708 Disease Process

1048708 Medication Use

1048708 Lifestyle Changes

1048708 Fluid Restriction

1048708 Sodium Restriction

1048708 Pre Transplant Immunizations

1048708 Clinic Follow up

042123 12dr yekehfallah-phd of nursing -2015

Donor Selection

Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed

cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors

1048708 Traumatic injury to the heart

042123 13dr yekehfallah-phd of nursing -2015

Donor Selection1048708 Negative serologies

1048708 No active systemic infection

1048708 No extracranial malignancies

1048708 No history IV drug use

1048708

1048708 Coronary Angiography for donors over

40yrs of age

042123 14dr yekehfallah-phd of nursing -2015

042123 15dr yekehfallah-phd of nursing -2015

042123 dr yekehfallah-phd of nursing -2015 16

042123 17dr yekehfallah-phd of nursing -2015

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 2: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Heart Transplant1048708 1960s

1048708 First heart transplants performed

1048708 1980s

1048708 Anti-rejection meds became available (Cyclosporine)

1048708 Today

1048708 About 80 of heart transplants are alive two years after the operation

1048708 50 percent survive 5 years

042123 2dr yekehfallah-phd of nursing -2015

Clinical Indications forHeart Transplant

1048708 Ischemic cardiomyopathy

1048708 Idiopathic cardiomyopathy

1048708 Viral cardiomyopathy

1048708 Congenital heart disease

1048708 Valvular heart disease

042123 3dr yekehfallah-phd of nursing -2015

Heart Transplant Contraindications

Absolute ContraindicationsI A Systemic illness that will limit survival despite heart

translplantII NeoplasmIII HIVAIDS CDC definition of CD4 count of lt 200 cellsmm3

IV SLE or Sarcoid that has multisystem involvement and is still active

V Any systemic illness with a high probability of recurrence in the transplanted heart

VI B Fixed pulmonary hypertension

042123 4dr yekehfallah-phd of nursing -2015

Heart Transplant Contraindications Relative Contraindications

Age over 65 Peripheral vascular disease Asymptomatic carotid stenosis gt 75 or symptomatic

carotid stenosis of less severity

Uncorrected abdominal aortic aneurysm gt 4 ndash 6 cm Systemic infection making immune suppression risky

HIV HBV CMV (positive donor to negative recipient) Severe pulmonary disease

042123 5dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Left andor Right Heart Catherization

1048708 Echocardiogram

1048708 EKG

1048708 24 hour Holter Monitor

1048708 Carotid and peripheral doppler flow studies

1048708 Cardiopulmonary Stress Test

1048708 Metabolic exercise test that determines the

maximal oxygen consumption

042123 6dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Pulmonary

1048708 Chest radiograph

1048708 CT Chest

1048708 PFTrsquos ndash baseline screening spirometry

042123 7dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Renal

1048708 Urinalysis

1048708 24 hour urine for creatinine clearance

1048708 Renal ultrasound

1048708 Gastrointestinal

1048708 Stool guiac

1048708 Abdominal ultrasound

1048708 CT abdominal and pelvis

1048708 Colonoscopy

042123 8dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Antibody screen

1048708 HLA typing

1048708 Infectious disease serologies

1048708 General laboratory studies

1048708 Bone density scan

1048708 Cancer screens ndash gender specific tests

042123 9dr yekehfallah-phd of nursing -2015

Social Services Psychiatry NeuropsychiatryConsults and Evaluation

1048708 Compliance

1048708 Support

1048708 Depression

1048708 Anxiety

1048708 Substance abuse

1048708 Finances

1048708 Knowledge deficits

042123 10dr yekehfallah-phd of nursing -2015

Medical Management of Patientson Waiting List

Comprehensive CHF Management

Program

042123 11dr yekehfallah-phd of nursing -2015

Patient Education

1048708 Disease Process

1048708 Medication Use

1048708 Lifestyle Changes

1048708 Fluid Restriction

1048708 Sodium Restriction

1048708 Pre Transplant Immunizations

1048708 Clinic Follow up

042123 12dr yekehfallah-phd of nursing -2015

Donor Selection

Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed

cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors

1048708 Traumatic injury to the heart

042123 13dr yekehfallah-phd of nursing -2015

Donor Selection1048708 Negative serologies

1048708 No active systemic infection

1048708 No extracranial malignancies

1048708 No history IV drug use

1048708

1048708 Coronary Angiography for donors over

40yrs of age

042123 14dr yekehfallah-phd of nursing -2015

042123 15dr yekehfallah-phd of nursing -2015

042123 dr yekehfallah-phd of nursing -2015 16

042123 17dr yekehfallah-phd of nursing -2015

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 3: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Clinical Indications forHeart Transplant

1048708 Ischemic cardiomyopathy

1048708 Idiopathic cardiomyopathy

1048708 Viral cardiomyopathy

1048708 Congenital heart disease

1048708 Valvular heart disease

042123 3dr yekehfallah-phd of nursing -2015

Heart Transplant Contraindications

Absolute ContraindicationsI A Systemic illness that will limit survival despite heart

translplantII NeoplasmIII HIVAIDS CDC definition of CD4 count of lt 200 cellsmm3

IV SLE or Sarcoid that has multisystem involvement and is still active

V Any systemic illness with a high probability of recurrence in the transplanted heart

VI B Fixed pulmonary hypertension

042123 4dr yekehfallah-phd of nursing -2015

Heart Transplant Contraindications Relative Contraindications

Age over 65 Peripheral vascular disease Asymptomatic carotid stenosis gt 75 or symptomatic

carotid stenosis of less severity

Uncorrected abdominal aortic aneurysm gt 4 ndash 6 cm Systemic infection making immune suppression risky

HIV HBV CMV (positive donor to negative recipient) Severe pulmonary disease

042123 5dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Left andor Right Heart Catherization

1048708 Echocardiogram

1048708 EKG

1048708 24 hour Holter Monitor

1048708 Carotid and peripheral doppler flow studies

1048708 Cardiopulmonary Stress Test

1048708 Metabolic exercise test that determines the

maximal oxygen consumption

042123 6dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Pulmonary

1048708 Chest radiograph

1048708 CT Chest

1048708 PFTrsquos ndash baseline screening spirometry

042123 7dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Renal

1048708 Urinalysis

1048708 24 hour urine for creatinine clearance

1048708 Renal ultrasound

1048708 Gastrointestinal

1048708 Stool guiac

1048708 Abdominal ultrasound

1048708 CT abdominal and pelvis

1048708 Colonoscopy

042123 8dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Antibody screen

1048708 HLA typing

1048708 Infectious disease serologies

1048708 General laboratory studies

1048708 Bone density scan

1048708 Cancer screens ndash gender specific tests

042123 9dr yekehfallah-phd of nursing -2015

Social Services Psychiatry NeuropsychiatryConsults and Evaluation

1048708 Compliance

1048708 Support

1048708 Depression

1048708 Anxiety

1048708 Substance abuse

1048708 Finances

1048708 Knowledge deficits

042123 10dr yekehfallah-phd of nursing -2015

Medical Management of Patientson Waiting List

Comprehensive CHF Management

Program

042123 11dr yekehfallah-phd of nursing -2015

Patient Education

1048708 Disease Process

1048708 Medication Use

1048708 Lifestyle Changes

1048708 Fluid Restriction

1048708 Sodium Restriction

1048708 Pre Transplant Immunizations

1048708 Clinic Follow up

042123 12dr yekehfallah-phd of nursing -2015

Donor Selection

Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed

cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors

1048708 Traumatic injury to the heart

042123 13dr yekehfallah-phd of nursing -2015

Donor Selection1048708 Negative serologies

1048708 No active systemic infection

1048708 No extracranial malignancies

1048708 No history IV drug use

1048708

1048708 Coronary Angiography for donors over

40yrs of age

042123 14dr yekehfallah-phd of nursing -2015

042123 15dr yekehfallah-phd of nursing -2015

042123 dr yekehfallah-phd of nursing -2015 16

042123 17dr yekehfallah-phd of nursing -2015

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 4: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Heart Transplant Contraindications

Absolute ContraindicationsI A Systemic illness that will limit survival despite heart

translplantII NeoplasmIII HIVAIDS CDC definition of CD4 count of lt 200 cellsmm3

IV SLE or Sarcoid that has multisystem involvement and is still active

V Any systemic illness with a high probability of recurrence in the transplanted heart

VI B Fixed pulmonary hypertension

042123 4dr yekehfallah-phd of nursing -2015

Heart Transplant Contraindications Relative Contraindications

Age over 65 Peripheral vascular disease Asymptomatic carotid stenosis gt 75 or symptomatic

carotid stenosis of less severity

Uncorrected abdominal aortic aneurysm gt 4 ndash 6 cm Systemic infection making immune suppression risky

HIV HBV CMV (positive donor to negative recipient) Severe pulmonary disease

042123 5dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Left andor Right Heart Catherization

1048708 Echocardiogram

1048708 EKG

1048708 24 hour Holter Monitor

1048708 Carotid and peripheral doppler flow studies

1048708 Cardiopulmonary Stress Test

1048708 Metabolic exercise test that determines the

maximal oxygen consumption

042123 6dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Pulmonary

1048708 Chest radiograph

1048708 CT Chest

1048708 PFTrsquos ndash baseline screening spirometry

042123 7dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Renal

1048708 Urinalysis

1048708 24 hour urine for creatinine clearance

1048708 Renal ultrasound

1048708 Gastrointestinal

1048708 Stool guiac

1048708 Abdominal ultrasound

1048708 CT abdominal and pelvis

1048708 Colonoscopy

042123 8dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Antibody screen

1048708 HLA typing

1048708 Infectious disease serologies

1048708 General laboratory studies

1048708 Bone density scan

1048708 Cancer screens ndash gender specific tests

042123 9dr yekehfallah-phd of nursing -2015

Social Services Psychiatry NeuropsychiatryConsults and Evaluation

1048708 Compliance

1048708 Support

1048708 Depression

1048708 Anxiety

1048708 Substance abuse

1048708 Finances

1048708 Knowledge deficits

042123 10dr yekehfallah-phd of nursing -2015

Medical Management of Patientson Waiting List

Comprehensive CHF Management

Program

042123 11dr yekehfallah-phd of nursing -2015

Patient Education

1048708 Disease Process

1048708 Medication Use

1048708 Lifestyle Changes

1048708 Fluid Restriction

1048708 Sodium Restriction

1048708 Pre Transplant Immunizations

1048708 Clinic Follow up

042123 12dr yekehfallah-phd of nursing -2015

Donor Selection

Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed

cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors

1048708 Traumatic injury to the heart

042123 13dr yekehfallah-phd of nursing -2015

Donor Selection1048708 Negative serologies

1048708 No active systemic infection

1048708 No extracranial malignancies

1048708 No history IV drug use

1048708

1048708 Coronary Angiography for donors over

40yrs of age

042123 14dr yekehfallah-phd of nursing -2015

042123 15dr yekehfallah-phd of nursing -2015

042123 dr yekehfallah-phd of nursing -2015 16

042123 17dr yekehfallah-phd of nursing -2015

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 5: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Heart Transplant Contraindications Relative Contraindications

Age over 65 Peripheral vascular disease Asymptomatic carotid stenosis gt 75 or symptomatic

carotid stenosis of less severity

Uncorrected abdominal aortic aneurysm gt 4 ndash 6 cm Systemic infection making immune suppression risky

HIV HBV CMV (positive donor to negative recipient) Severe pulmonary disease

042123 5dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Left andor Right Heart Catherization

1048708 Echocardiogram

1048708 EKG

1048708 24 hour Holter Monitor

1048708 Carotid and peripheral doppler flow studies

1048708 Cardiopulmonary Stress Test

1048708 Metabolic exercise test that determines the

maximal oxygen consumption

042123 6dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Pulmonary

1048708 Chest radiograph

1048708 CT Chest

1048708 PFTrsquos ndash baseline screening spirometry

042123 7dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Renal

1048708 Urinalysis

1048708 24 hour urine for creatinine clearance

1048708 Renal ultrasound

1048708 Gastrointestinal

1048708 Stool guiac

1048708 Abdominal ultrasound

1048708 CT abdominal and pelvis

1048708 Colonoscopy

042123 8dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Antibody screen

1048708 HLA typing

1048708 Infectious disease serologies

1048708 General laboratory studies

1048708 Bone density scan

1048708 Cancer screens ndash gender specific tests

042123 9dr yekehfallah-phd of nursing -2015

Social Services Psychiatry NeuropsychiatryConsults and Evaluation

1048708 Compliance

1048708 Support

1048708 Depression

1048708 Anxiety

1048708 Substance abuse

1048708 Finances

1048708 Knowledge deficits

042123 10dr yekehfallah-phd of nursing -2015

Medical Management of Patientson Waiting List

Comprehensive CHF Management

Program

042123 11dr yekehfallah-phd of nursing -2015

Patient Education

1048708 Disease Process

1048708 Medication Use

1048708 Lifestyle Changes

1048708 Fluid Restriction

1048708 Sodium Restriction

1048708 Pre Transplant Immunizations

1048708 Clinic Follow up

042123 12dr yekehfallah-phd of nursing -2015

Donor Selection

Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed

cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors

1048708 Traumatic injury to the heart

042123 13dr yekehfallah-phd of nursing -2015

Donor Selection1048708 Negative serologies

1048708 No active systemic infection

1048708 No extracranial malignancies

1048708 No history IV drug use

1048708

1048708 Coronary Angiography for donors over

40yrs of age

042123 14dr yekehfallah-phd of nursing -2015

042123 15dr yekehfallah-phd of nursing -2015

042123 dr yekehfallah-phd of nursing -2015 16

042123 17dr yekehfallah-phd of nursing -2015

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 6: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Transplant Evaluation

1048708 Left andor Right Heart Catherization

1048708 Echocardiogram

1048708 EKG

1048708 24 hour Holter Monitor

1048708 Carotid and peripheral doppler flow studies

1048708 Cardiopulmonary Stress Test

1048708 Metabolic exercise test that determines the

maximal oxygen consumption

042123 6dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Pulmonary

1048708 Chest radiograph

1048708 CT Chest

1048708 PFTrsquos ndash baseline screening spirometry

042123 7dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Renal

1048708 Urinalysis

1048708 24 hour urine for creatinine clearance

1048708 Renal ultrasound

1048708 Gastrointestinal

1048708 Stool guiac

1048708 Abdominal ultrasound

1048708 CT abdominal and pelvis

1048708 Colonoscopy

042123 8dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Antibody screen

1048708 HLA typing

1048708 Infectious disease serologies

1048708 General laboratory studies

1048708 Bone density scan

1048708 Cancer screens ndash gender specific tests

042123 9dr yekehfallah-phd of nursing -2015

Social Services Psychiatry NeuropsychiatryConsults and Evaluation

1048708 Compliance

1048708 Support

1048708 Depression

1048708 Anxiety

1048708 Substance abuse

1048708 Finances

1048708 Knowledge deficits

042123 10dr yekehfallah-phd of nursing -2015

Medical Management of Patientson Waiting List

Comprehensive CHF Management

Program

042123 11dr yekehfallah-phd of nursing -2015

Patient Education

1048708 Disease Process

1048708 Medication Use

1048708 Lifestyle Changes

1048708 Fluid Restriction

1048708 Sodium Restriction

1048708 Pre Transplant Immunizations

1048708 Clinic Follow up

042123 12dr yekehfallah-phd of nursing -2015

Donor Selection

Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed

cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors

1048708 Traumatic injury to the heart

042123 13dr yekehfallah-phd of nursing -2015

Donor Selection1048708 Negative serologies

1048708 No active systemic infection

1048708 No extracranial malignancies

1048708 No history IV drug use

1048708

1048708 Coronary Angiography for donors over

40yrs of age

042123 14dr yekehfallah-phd of nursing -2015

042123 15dr yekehfallah-phd of nursing -2015

042123 dr yekehfallah-phd of nursing -2015 16

042123 17dr yekehfallah-phd of nursing -2015

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 7: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Transplant Evaluation

1048708 Pulmonary

1048708 Chest radiograph

1048708 CT Chest

1048708 PFTrsquos ndash baseline screening spirometry

042123 7dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Renal

1048708 Urinalysis

1048708 24 hour urine for creatinine clearance

1048708 Renal ultrasound

1048708 Gastrointestinal

1048708 Stool guiac

1048708 Abdominal ultrasound

1048708 CT abdominal and pelvis

1048708 Colonoscopy

042123 8dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Antibody screen

1048708 HLA typing

1048708 Infectious disease serologies

1048708 General laboratory studies

1048708 Bone density scan

1048708 Cancer screens ndash gender specific tests

042123 9dr yekehfallah-phd of nursing -2015

Social Services Psychiatry NeuropsychiatryConsults and Evaluation

1048708 Compliance

1048708 Support

1048708 Depression

1048708 Anxiety

1048708 Substance abuse

1048708 Finances

1048708 Knowledge deficits

042123 10dr yekehfallah-phd of nursing -2015

Medical Management of Patientson Waiting List

Comprehensive CHF Management

Program

042123 11dr yekehfallah-phd of nursing -2015

Patient Education

1048708 Disease Process

1048708 Medication Use

1048708 Lifestyle Changes

1048708 Fluid Restriction

1048708 Sodium Restriction

1048708 Pre Transplant Immunizations

1048708 Clinic Follow up

042123 12dr yekehfallah-phd of nursing -2015

Donor Selection

Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed

cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors

1048708 Traumatic injury to the heart

042123 13dr yekehfallah-phd of nursing -2015

Donor Selection1048708 Negative serologies

1048708 No active systemic infection

1048708 No extracranial malignancies

1048708 No history IV drug use

1048708

1048708 Coronary Angiography for donors over

40yrs of age

042123 14dr yekehfallah-phd of nursing -2015

042123 15dr yekehfallah-phd of nursing -2015

042123 dr yekehfallah-phd of nursing -2015 16

042123 17dr yekehfallah-phd of nursing -2015

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 8: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Transplant Evaluation

1048708 Renal

1048708 Urinalysis

1048708 24 hour urine for creatinine clearance

1048708 Renal ultrasound

1048708 Gastrointestinal

1048708 Stool guiac

1048708 Abdominal ultrasound

1048708 CT abdominal and pelvis

1048708 Colonoscopy

042123 8dr yekehfallah-phd of nursing -2015

Transplant Evaluation

1048708 Antibody screen

1048708 HLA typing

1048708 Infectious disease serologies

1048708 General laboratory studies

1048708 Bone density scan

1048708 Cancer screens ndash gender specific tests

042123 9dr yekehfallah-phd of nursing -2015

Social Services Psychiatry NeuropsychiatryConsults and Evaluation

1048708 Compliance

1048708 Support

1048708 Depression

1048708 Anxiety

1048708 Substance abuse

1048708 Finances

1048708 Knowledge deficits

042123 10dr yekehfallah-phd of nursing -2015

Medical Management of Patientson Waiting List

Comprehensive CHF Management

Program

042123 11dr yekehfallah-phd of nursing -2015

Patient Education

1048708 Disease Process

1048708 Medication Use

1048708 Lifestyle Changes

1048708 Fluid Restriction

1048708 Sodium Restriction

1048708 Pre Transplant Immunizations

1048708 Clinic Follow up

042123 12dr yekehfallah-phd of nursing -2015

Donor Selection

Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed

cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors

1048708 Traumatic injury to the heart

042123 13dr yekehfallah-phd of nursing -2015

Donor Selection1048708 Negative serologies

1048708 No active systemic infection

1048708 No extracranial malignancies

1048708 No history IV drug use

1048708

1048708 Coronary Angiography for donors over

40yrs of age

042123 14dr yekehfallah-phd of nursing -2015

042123 15dr yekehfallah-phd of nursing -2015

042123 dr yekehfallah-phd of nursing -2015 16

042123 17dr yekehfallah-phd of nursing -2015

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 9: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Transplant Evaluation

1048708 Antibody screen

1048708 HLA typing

1048708 Infectious disease serologies

1048708 General laboratory studies

1048708 Bone density scan

1048708 Cancer screens ndash gender specific tests

042123 9dr yekehfallah-phd of nursing -2015

Social Services Psychiatry NeuropsychiatryConsults and Evaluation

1048708 Compliance

1048708 Support

1048708 Depression

1048708 Anxiety

1048708 Substance abuse

1048708 Finances

1048708 Knowledge deficits

042123 10dr yekehfallah-phd of nursing -2015

Medical Management of Patientson Waiting List

Comprehensive CHF Management

Program

042123 11dr yekehfallah-phd of nursing -2015

Patient Education

1048708 Disease Process

1048708 Medication Use

1048708 Lifestyle Changes

1048708 Fluid Restriction

1048708 Sodium Restriction

1048708 Pre Transplant Immunizations

1048708 Clinic Follow up

042123 12dr yekehfallah-phd of nursing -2015

Donor Selection

Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed

cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors

1048708 Traumatic injury to the heart

042123 13dr yekehfallah-phd of nursing -2015

Donor Selection1048708 Negative serologies

1048708 No active systemic infection

1048708 No extracranial malignancies

1048708 No history IV drug use

1048708

1048708 Coronary Angiography for donors over

40yrs of age

042123 14dr yekehfallah-phd of nursing -2015

042123 15dr yekehfallah-phd of nursing -2015

042123 dr yekehfallah-phd of nursing -2015 16

042123 17dr yekehfallah-phd of nursing -2015

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 10: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Social Services Psychiatry NeuropsychiatryConsults and Evaluation

1048708 Compliance

1048708 Support

1048708 Depression

1048708 Anxiety

1048708 Substance abuse

1048708 Finances

1048708 Knowledge deficits

042123 10dr yekehfallah-phd of nursing -2015

Medical Management of Patientson Waiting List

Comprehensive CHF Management

Program

042123 11dr yekehfallah-phd of nursing -2015

Patient Education

1048708 Disease Process

1048708 Medication Use

1048708 Lifestyle Changes

1048708 Fluid Restriction

1048708 Sodium Restriction

1048708 Pre Transplant Immunizations

1048708 Clinic Follow up

042123 12dr yekehfallah-phd of nursing -2015

Donor Selection

Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed

cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors

1048708 Traumatic injury to the heart

042123 13dr yekehfallah-phd of nursing -2015

Donor Selection1048708 Negative serologies

1048708 No active systemic infection

1048708 No extracranial malignancies

1048708 No history IV drug use

1048708

1048708 Coronary Angiography for donors over

40yrs of age

042123 14dr yekehfallah-phd of nursing -2015

042123 15dr yekehfallah-phd of nursing -2015

042123 dr yekehfallah-phd of nursing -2015 16

042123 17dr yekehfallah-phd of nursing -2015

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 11: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Medical Management of Patientson Waiting List

Comprehensive CHF Management

Program

042123 11dr yekehfallah-phd of nursing -2015

Patient Education

1048708 Disease Process

1048708 Medication Use

1048708 Lifestyle Changes

1048708 Fluid Restriction

1048708 Sodium Restriction

1048708 Pre Transplant Immunizations

1048708 Clinic Follow up

042123 12dr yekehfallah-phd of nursing -2015

Donor Selection

Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed

cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors

1048708 Traumatic injury to the heart

042123 13dr yekehfallah-phd of nursing -2015

Donor Selection1048708 Negative serologies

1048708 No active systemic infection

1048708 No extracranial malignancies

1048708 No history IV drug use

1048708

1048708 Coronary Angiography for donors over

40yrs of age

042123 14dr yekehfallah-phd of nursing -2015

042123 15dr yekehfallah-phd of nursing -2015

042123 dr yekehfallah-phd of nursing -2015 16

042123 17dr yekehfallah-phd of nursing -2015

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 12: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Patient Education

1048708 Disease Process

1048708 Medication Use

1048708 Lifestyle Changes

1048708 Fluid Restriction

1048708 Sodium Restriction

1048708 Pre Transplant Immunizations

1048708 Clinic Follow up

042123 12dr yekehfallah-phd of nursing -2015

Donor Selection

Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed

cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors

1048708 Traumatic injury to the heart

042123 13dr yekehfallah-phd of nursing -2015

Donor Selection1048708 Negative serologies

1048708 No active systemic infection

1048708 No extracranial malignancies

1048708 No history IV drug use

1048708

1048708 Coronary Angiography for donors over

40yrs of age

042123 14dr yekehfallah-phd of nursing -2015

042123 15dr yekehfallah-phd of nursing -2015

042123 dr yekehfallah-phd of nursing -2015 16

042123 17dr yekehfallah-phd of nursing -2015

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 13: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Donor Selection

Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed

cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors

1048708 Traumatic injury to the heart

042123 13dr yekehfallah-phd of nursing -2015

Donor Selection1048708 Negative serologies

1048708 No active systemic infection

1048708 No extracranial malignancies

1048708 No history IV drug use

1048708

1048708 Coronary Angiography for donors over

40yrs of age

042123 14dr yekehfallah-phd of nursing -2015

042123 15dr yekehfallah-phd of nursing -2015

042123 dr yekehfallah-phd of nursing -2015 16

042123 17dr yekehfallah-phd of nursing -2015

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 14: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Donor Selection1048708 Negative serologies

1048708 No active systemic infection

1048708 No extracranial malignancies

1048708 No history IV drug use

1048708

1048708 Coronary Angiography for donors over

40yrs of age

042123 14dr yekehfallah-phd of nursing -2015

042123 15dr yekehfallah-phd of nursing -2015

042123 dr yekehfallah-phd of nursing -2015 16

042123 17dr yekehfallah-phd of nursing -2015

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 15: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

042123 15dr yekehfallah-phd of nursing -2015

042123 dr yekehfallah-phd of nursing -2015 16

042123 17dr yekehfallah-phd of nursing -2015

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 16: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

042123 dr yekehfallah-phd of nursing -2015 16

042123 17dr yekehfallah-phd of nursing -2015

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 17: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

042123 17dr yekehfallah-phd of nursing -2015

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 18: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

042123 18dr yekehfallah-phd of nursing -2015

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 19: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

042123 19dr yekehfallah-phd of nursing -2015

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 20: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

042123 20dr yekehfallah-phd of nursing -2015

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 21: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

042123 21dr yekehfallah-phd of nursing -2015

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 22: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Major Post Transplant Complications

Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy

042123 22dr yekehfallah-phd of nursing -2015

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 23: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Rejection Invasive surveillance biopsies are the best established method for following patients

Typically 13-15 biopsies are done in the first year

Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful

A new biopsy grading has been developed for widespread adoption

042123 23dr yekehfallah-phd of nursing -2015

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 24: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

042123 24dr yekehfallah-phd of nursing -2015

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 25: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

042123 25dr yekehfallah-phd of nursing -2015

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 26: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies

Rejection grade Description0 No evidence of rejection

1 - Mild A - Focal

Focal perivascular andor interstitial infiltrate without myocyte damage

B - Diffuse Diffuse infiltrate without myocyte damage

2 - Moderate (focal) One focus of infiltrate with myocyte damage

3 - ModerateA - Multifocal

Multifocal infiltrate with myocyte damage

MultifocalB - Diffuse

Diffuse infiltrate with myocyte damage

4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis

26042123 dr yekehfallah-phd of nursing -2015

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 27: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

GRADE 1A

GRADE 2

GRADE 1B

042123 dr yekehfallah-phd of nursing -2015 27

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 28: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

GRADE 4

GRADE 3A GRADE 3B

ThresholdMandatory

ForTherapy

042123 28dr yekehfallah-phd of nursing -2015

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 29: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Treatment of Rejection

Rejection without hemodynamic compromise

Oral prednisone (100 mg daily for 3 days)

IV steroids

Decision dependent on grading severity and time post transplantation

Steroid resistant rejection with or without hemodynamic compromise

Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation

042123 29dr yekehfallah-phd of nursing -2015

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 30: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Long Term Challenges

Renal failure and metabolic adverse effects

Cardiac allograft vasculopathy Malignancy

042123 30dr yekehfallah-phd of nursing -2015

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 31: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

042123 31dr yekehfallah-phd of nursing -2015

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 32: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution

042123 32dr yekehfallah-phd of nursing -2015

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 33: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

042123 33dr yekehfallah-phd of nursing -2015

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 34: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Transmedics Inc

042123 34dr yekehfallah-phd of nursing -2015

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 35: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Heart Preservation Device2nd GenerationDevices

042123 35dr yekehfallah-phd of nursing -2015

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 36: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Postoperative TransplantManagement

042123 36dr yekehfallah-phd of nursing -2015

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 37: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Survival Following Transplant

1048708 Operative mortality rate is between 5-10

1048708 Other leading causes of mortality include1048708 Infection (15-20)

1048708 Acute RV failure

1048708 Rejection

042123 37dr yekehfallah-phd of nursing -2015

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 38: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Postoperative ManagementComplicated by

1048708 Denervation

1048708 Global ischemic injury associated with

perfusion injury

1048708 Myocardial dysfunction

1048708 Dysrhythmia

1048708 Hypertension

1048708 Pulmonary Hypertension

042123 38dr yekehfallah-phd of nursing -2015

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 39: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Infection Post Transplant

1048708 Prophylaxis

1048708 Viral - CMV

1048708 Pneumocystis carinii

1048708 Fungal

1048708 Based on recipient and donor serologies

bull Toxoplasmosis

bull TB

bull Cocci042123 39dr yekehfallah-phd of nursing -2015

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 40: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

TRANSPLANT REJECTION

1048708 Three types of transplant rejection

1048708 Hyperacute

1048708 Acute

1048708 Chronic

042123 40dr yekehfallah-phd of nursing -2015

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 41: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708

042123 41dr yekehfallah-phd of nursing -2015

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 42: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Immunosuppression Balance

042123 42dr yekehfallah-phd of nursing -2015

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 43: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Recovery Phase

Hospital Discharge

042123 43dr yekehfallah-phd of nursing -2015

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 44: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Home Assessment

1048708 Weight

1048708 Blood pressure

1048708 Heart rate

1048708 Temperature

1048708 Blood sugar monitoring

042123 44dr yekehfallah-phd of nursing -2015

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 45: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Routine Testing

1048708 Lab work

1048708 Chest X-ray

1048708 EKG

1048708 Endomyocardial biopsy and or AlloMap

1048708 Echocardiogram

1048708 Bone Densitometry

042123 45dr yekehfallah-phd of nursing -2015

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 46: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Transplant Clinic Visits

1048708 Health Maintenance follow-up

1048708 Continuing education

1048708 Psychosocial issues

042123 46dr yekehfallah-phd of nursing -2015

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 47: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Cardiac Rehabilitation

1048708 Heart rate response to exercise is blunted and

delayed

1048708 Increase in heart rate is caused by circulating

catecholamines

1048708 Maximum heart rate is achieved after exercise is

completed

1048708 Deceleration of heart rate is gradual and

prolonged

042123 47dr yekehfallah-phd of nursing -2015

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 48: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Long Term Follow Up

Management and Complications

042123 48dr yekehfallah-phd of nursing -2015

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 49: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Medical Issues

1048708 Immunosuppression

1048708 Infection

1048708 Rejection

1048708 Coronary artery

vasculopathy

1048708 Hypertension

1048708 Hyperlipidemia

1048708 Diabetes

1048708 Osteoporosis

1048708 Obesity

1048708 Renal insufficiency

1048708 Gastrointestinal disorders

1048708 Reduced exercise

tolerance

1048708 Malignancy

1048708 Poor compliance

1048708 Depression

042123 49dr yekehfallah-phd of nursing -2015

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 50: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Quality of Life Issues

The functional effect of an illness and its

consequent therapy upon a patient as

perceived by the patient

bull Reproduction and Sexuality

bull Recurrent Disease

bull Travel

bull Adjustment

042123 50dr yekehfallah-phd of nursing -2015

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 51: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Mental and Emotional Health

1048708 Quality of Life

1048708 Psychiatric Disorders

1048708 Body Image

1048708 Social Adaptation

1048708 Family Dynamics

1048708 Financial Burdens

042123 51dr yekehfallah-phd of nursing -2015

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 52: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Return to Work vsDisability Issues

1048708 Insurance

1048708 Employment

1048708 Vocational Rehab

1048708 Disabilities

042123 52dr yekehfallah-phd of nursing -2015

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 53: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

Yearly Evaluation

1048708 Cardiac catherization with Intravascular Ultrasound

1048708 Echo

1048708 Dobutamine Stress Echo

1048708 Abdominal Ultrasound

1048708 Chest X-Ray

1048708 Bone Density Scan

1048708 Labs

1048708 24-hour urine for creatinine clearance

1048708 Cancer Screens

042123 53dr yekehfallah-phd of nursing -2015

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 54: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

042123 54dr yekehfallah-phd of nursing -2015

042123 55dr yekehfallah-phd of nursing -2015

Page 55: Critical Care of Heart Transplantation. Heart Transplant 1960s: First heart transplants performed 1980s: Anti-rejection meds became available (Cyclosporine)

042123 55dr yekehfallah-phd of nursing -2015